ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT
Journal of Blood Medicine · 2026-06 · Volume 17 · 1-12
DOI: 10.2147/jbm.s593133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-06. Verfasst von Min Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
- Department of Hematology, Jingzhou Hospital, Affiliated to Yangtze University, Jingzhou, People's Republic of China.
ORCID-Profile: Min Liu
Zitieren
APA
Liu, M., Yu, Q., Cao, Y., Ma, Y., Hong, Z., Yin, Q., Feng, Y., Li, T., Zhang, Y., & Zheng, M. (2026). ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT. Journal of Blood Medicine, Volume 17, 1-12. https://doi.org/10.2147/jbm.s593133
Vancouver
Liu M, Yu Q, Cao Y, Ma Y, Hong Z, Yin Q, et al. ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT. Journal of Blood Medicine. 2026;Volume 17:1-12. doi:10.2147/jbm.s593133
BibTeX
@article{Liu2026,
author = {Liu, Min and Yu, Qiuxia and Cao, Yang and Ma, Yaxian and Hong, Zetong and Yin, Qing and Feng, Yan and Li, Tongjuan and Zhang, Yicheng and Zheng, Miao},
title = {ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--12},
doi = {10.2147/jbm.s593133}
}
EUVIMED